Anna Melisa Lopez-Sanglay, APRN
Family · Las Vegas, NVNPI 1245647528
Payments from drug & device makers
Across 879 payments — averaging $47.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Dermavant Sciences, Inc.$4K
- Organon$4K
- UCB, Inc.$3K
- Arcutis Biotherapeutics, Inc.$3K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $18K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 118 | $6,296 |
| Dermavant Sciences, Inc. | 27 | $4,211 |
| Organon | 7 | $3,972 |
| UCB, Inc. | 84 | $3,395 |
| Arcutis Biotherapeutics, Inc. | 97 | $3,103 |
| E.r. Squibb & Sons, L.L.C. | 123 | $2,471 |
| LEO Pharma Inc. | 40 | $2,418 |
| Sanofi | 60 | $2,320 |
| Sun Pharmaceutical Industries Inc. | 70 | $2,303 |
| Incyte Corporation | 19 | $2,180 |
| Pfizer | 56 | $1,809 |
| Johnson & Johnson | 36 | $1,274 |
| Galderma Laboratories, L.p. | 46 | $1,241 |
| Regeneron Healthcare Solutions, Inc. | 23 | $1,051 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $1,039 |
| Lilly USA, LLC | 14 | $653 |
| Amgen | 23 | $596 |
| Journey Medical Corporation | 5 | $279 |
| Janssen Scientific Affairs, LLC | 2 | $273 |
| Novartis | 6 | $200 |
| Regeneron | 1 | $132 |
| Botanix SB Inc | 3 | $64 |
| Stemline Therapeutics Inc. | 1 | $57 |
| Biofrontera Inc. | 3 | $54 |
| Merz North America, Inc. | 1 | $28 |
| Novo Nordisk | 1 | $28 |
| Almirall LLC | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$41,554 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Las Vegas
- John PhoenixLas Vegas$281K
- Hollie TylerLas Vegas$118K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Kelly PapeshLas Vegas$44K
- Erin WilkinsonLas Vegas$43K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
- Anuradha ThirumalaiLas Vegas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.